Adverse Outcomes with Eccentric Hypertrophy in a Community Based University Cohort with Aortic Stenosis

Steven J Lavine1, Kirsten Raby2

  • 1Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States; Washington University of St. Louis, St. Louis, MO, United States.

Insights

Aortic stenosis patients with eccentric left ventricular hypertrophy (Ecc-LVH) face increased risks of heart failure and all-cause mortality, particularly in moderate to severe cases. This finding highlights Ecc-LVH as a significant predictor of adverse outcomes in AS.

Area of Science:

  • Cardiology
  • Echocardiography
  • Clinical Outcomes

Background:

  • Aortic stenosis (AS) is a common valvular heart disease.
  • Left ventricular hypertrophy (LVH) is a known complication of AS.
  • The prognostic impact of different LVH patterns, specifically eccentric hypertrophy (Ecc-LVH), in AS requires further clarification.

Purpose of the Study:

  • To investigate the association between Ecc-LVH and adverse clinical outcomes in patients with aortic stenosis.
  • To determine if Ecc-LVH predicts heart failure (HF) and all-cause mortality (ACM) in AS patients.

Main Methods:

  • Retrospective analysis of electronic medical records for AS patients with Doppler echocardiograms.
  • Patients were categorized into four groups based on LVH and relative wall thickness (RWT).
  • Multivariate Cox proportional analysis was used to identify predictors of HF and ACM.

Main Results:

  • Eccentric LVH (RWT<0.43 and LVH) was identified as a predictor for both HF and ACM in AS patients.
  • Patients with AS and Ecc-LVH exhibited significantly increased ACM across moderate and severe AS stages.
  • Ecc-LVH was also associated with a higher incidence of HF in moderate AS.

Conclusions:

  • Eccentric left ventricular hypertrophy is an independent predictor of worse outcomes in aortic stenosis.
  • AS patients with Ecc-LVH experience higher rates of all-cause mortality and heart failure compared to other LV geometric patterns.
  • These findings underscore the importance of recognizing Ecc-LVH in risk stratification and management of AS.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
85
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
94
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
84
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
99
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
108
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
55